Cargando…
MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background
MECP2 mutations cause a number of neurological disorders of which Rett syndrome (RTT) represents the most thoroughly analysed condition. Many Mecp2 mouse models have been generated through the years; their validity is demonstrated by the presence of a broad spectrum of phenotypes largely mimicking t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838291/ https://www.ncbi.nlm.nih.gov/pubmed/27097329 http://dx.doi.org/10.1371/journal.pone.0153473 |
_version_ | 1782427965607378944 |
---|---|
author | Cobolli Gigli, Clementina Scaramuzza, Linda Gandaglia, Anna Bellini, Elisa Gabaglio, Marina Parolaro, Daniela Kilstrup-Nielsen, Charlotte Landsberger, Nicoletta Bedogni, Francesco |
author_facet | Cobolli Gigli, Clementina Scaramuzza, Linda Gandaglia, Anna Bellini, Elisa Gabaglio, Marina Parolaro, Daniela Kilstrup-Nielsen, Charlotte Landsberger, Nicoletta Bedogni, Francesco |
author_sort | Cobolli Gigli, Clementina |
collection | PubMed |
description | MECP2 mutations cause a number of neurological disorders of which Rett syndrome (RTT) represents the most thoroughly analysed condition. Many Mecp2 mouse models have been generated through the years; their validity is demonstrated by the presence of a broad spectrum of phenotypes largely mimicking those manifested by RTT patients. These mouse models, between which the C57BL/6 Mecp2(tm1.1Bird) strain probably represents the most used, enabled to disclose much of the roles of Mecp2. However, small litters with little viability and poor maternal care hamper the maintenance of the colony, thus limiting research on such animals. For this reason, past studies often used Mecp2 mouse models on mixed genetic backgrounds, thus opening questions on whether modifier genes could be responsible for at least part of the described effects. To verify this possibility, and facilitate the maintenance of the Mecp2 colony, we transferred the Mecp2(tm1.1Bird) allele on the stronger CD1 background. The CD1 strain is easier to maintain and largely recapitulates the phenotypes already described in Mecp2-null mice. We believe that this mouse model will foster the research on RTT. |
format | Online Article Text |
id | pubmed-4838291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48382912016-04-29 MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background Cobolli Gigli, Clementina Scaramuzza, Linda Gandaglia, Anna Bellini, Elisa Gabaglio, Marina Parolaro, Daniela Kilstrup-Nielsen, Charlotte Landsberger, Nicoletta Bedogni, Francesco PLoS One Research Article MECP2 mutations cause a number of neurological disorders of which Rett syndrome (RTT) represents the most thoroughly analysed condition. Many Mecp2 mouse models have been generated through the years; their validity is demonstrated by the presence of a broad spectrum of phenotypes largely mimicking those manifested by RTT patients. These mouse models, between which the C57BL/6 Mecp2(tm1.1Bird) strain probably represents the most used, enabled to disclose much of the roles of Mecp2. However, small litters with little viability and poor maternal care hamper the maintenance of the colony, thus limiting research on such animals. For this reason, past studies often used Mecp2 mouse models on mixed genetic backgrounds, thus opening questions on whether modifier genes could be responsible for at least part of the described effects. To verify this possibility, and facilitate the maintenance of the Mecp2 colony, we transferred the Mecp2(tm1.1Bird) allele on the stronger CD1 background. The CD1 strain is easier to maintain and largely recapitulates the phenotypes already described in Mecp2-null mice. We believe that this mouse model will foster the research on RTT. Public Library of Science 2016-04-20 /pmc/articles/PMC4838291/ /pubmed/27097329 http://dx.doi.org/10.1371/journal.pone.0153473 Text en © 2016 Cobolli Gigli et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Cobolli Gigli, Clementina Scaramuzza, Linda Gandaglia, Anna Bellini, Elisa Gabaglio, Marina Parolaro, Daniela Kilstrup-Nielsen, Charlotte Landsberger, Nicoletta Bedogni, Francesco MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background |
title | MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background |
title_full | MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background |
title_fullStr | MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background |
title_full_unstemmed | MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background |
title_short | MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background |
title_sort | mecp2 related studies benefit from the use of cd1 as genetic background |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838291/ https://www.ncbi.nlm.nih.gov/pubmed/27097329 http://dx.doi.org/10.1371/journal.pone.0153473 |
work_keys_str_mv | AT cobolligigliclementina mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground AT scaramuzzalinda mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground AT gandagliaanna mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground AT bellinielisa mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground AT gabagliomarina mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground AT parolarodaniela mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground AT kilstrupnielsencharlotte mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground AT landsbergernicoletta mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground AT bedognifrancesco mecp2relatedstudiesbenefitfromtheuseofcd1asgeneticbackground |